Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “No Severe Allergic Reaction”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Large-scale testing (Phase 3)Study completedNCT03131648
What this trial is testing

Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1)

Who this might be right for
Atopic Dermatitis
LEO Pharma 802
Not applicableStudy completedNCT07154004
What this trial is testing

The Sponsor Assigns Test Products to Six Skin Areas According to a Concealed Randomization Schedule; Neither the Evaluating Physicians Nor the Participants Know Which Product is Applied to Which Site, Preventing Bias.

Who this might be right for
No ProtrusionNo Open WoundNo Severe Allergic Reaction+3 more
BEIJING YUANBEN INFORMATION CONSULTING CO., LTD 30
Not applicableStudy completedNCT03321877
What this trial is testing

Down-titration of Steroids in Patients With Difficult Asthma With no Bronchial Hyperreactivity

Who this might be right for
Asthma
Bispebjerg Hospital 9
Testing effectiveness (Phase 2)Study completedNCT05388760
What this trial is testing

Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1)

Who this might be right for
Atopic Dermatitis
LEO Pharma 28
Testing effectiveness (Phase 2)Study completedNCT03562377
What this trial is testing

Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)

Who this might be right for
Atopic Dermatitis
LEO Pharma 215
Large-scale testing (Phase 3)Study completedNCT03160885
What this trial is testing

Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2)

Who this might be right for
Atopic Dermatitis
LEO Pharma 794
Large-scale testing (Phase 3)Study completedNCT03526861
What this trial is testing

Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).

Who this might be right for
Atopic Dermatitis
LEO Pharma 301
Not applicableStudy completedNCT03964324
What this trial is testing

NO Measurements in Screening for Asthma and OSA, in Patients With Severe Snoring

Who this might be right for
SnoringObstructive Sleep ApneaAsthma+3 more
Christian von Buchwald 51